Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Market Cap	1.47B -12.3%
Revenue (ttm)	n/a -11.7%
Net Income	n/a
EPS	n/a
Shares Out	103.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.11 (0.77%)
Ex-Dividend Date	Dec 17, 2025

Volume	339,868
Average Volume	376,248
Open	14.10
Previous Close	14.10
Day's Range	14.10 - 14.40
52-Week Range	11.10 - 18.50
Beta	0.22
RSI	55.00
Earnings Date	Jan 29, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 313
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILCOPHL

Financial Performance

In fiscal year 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.